Gilead responds to Attorney General Maura Healey's warning to lower Hepatitis C drug price By Gintautas Dumcius |

Gilead Sciences Inc. has reached out to meet with Massachusetts Attorney General Maura Healey after she called the company out for charging $1,000 per pill in the U.S. as part of a Hepatitis C drug treatment.
At a Wednesday morning breakfast with biotechnology officials, Healey said that Hepatitis C virus (HCV) rates are rising in Massachusetts as medication like Sovaldi, the drug treatment from Gilead, sits on pharmacy shelves as people can't afford it.
In a letter to the California-based company sent last week, Healey said her office is weighing whether Gilead's pricing may fall under unfair trade practices, a violation of state law.

Labels: , ,